Clinical Trials Logo

Oxidative Stress clinical trials

View clinical trials related to Oxidative Stress.

Filter by:

NCT ID: NCT00444717 Completed - Metabolic Syndrome Clinical Trials

Impact of Pitavastatin in Hypercholesterolemic Patients With Metabolic Syndrome

Start date: April 2007
Phase: Phase 4
Study type: Interventional

The purpose of this study is to evaluate anti-oxidative and anti-inflammatory effects of pitavastatin in hypercholesterolemic patients with the metabolic syndrome.

NCT ID: NCT00387114 Terminated - Oxidative Stress Clinical Trials

Effect of an Anti-Oxidant Treatment on Resistin Serum Levels.A Randomized Study

Start date: June 2005
Phase: Phase 3
Study type: Interventional

The aim of the present study was to evaluate whether an in vivo treatment with an antioxidant vitamin (vitamin C) might substantially affect serum levels of resistin, a recently described adipokine, whose clinical significance is still controversial in humans.

NCT ID: NCT00324909 Completed - Inflammation Clinical Trials

Effects of Hyperbaric Oxygen Therapy in Autistic Children: A Pilot Study

Start date: n/a
Phase: N/A
Study type: Interventional

Autism is a neurodevelopmental disorder that currently affects as many as 1 out of 166 children in the United States. Autism is considered by many to be a permanent condition with little hope for improvement. Treatment for autism is centered on special schooling and behavioral therapy; medical science currently has little to offer. Recent research has discovered that some autistic individuals have decreased blood flow to the brain, evidence of inflammation in the brain, and increased markers of oxidative stress. Multiple independent single photon emission computed tomography (SPECT) and positron emission tomography (PET) research studies have revealed hypoperfusion to several areas of the autistic brain, most notably the temporal regions and areas specifically related to language comprehension and auditory processing. Several studies show that diminished blood flow to these areas correlates with many of the clinical features associated with autism including repetitive, self-stimulatory and stereotypical behaviors, and impairments in communication, sensory perception, and social interaction. Hyperbaric oxygen therapy (HBOT) has been used with clinical success in several cerebral hypoperfusion syndromes including cerebral palsy, fetal alcohol syndrome, closed head injury, and stroke. HBOT can compensate for decreased blood flow by increasing the oxygen content of plasma and body tissues and can even normalize oxygen levels in ischemic tissue. In addition, animal studies have shown that HBOT has potent anti-inflammatory effects and reduces oxidative stress. Furthermore, recent evidence demonstrates that HBOT mobilizes stem cells from human bone marrow which may aid recovery in neurodegenerative diseases. Based upon these findings, it is hypothesized that HBOT will improve symptoms in autistic individuals. The purpose of this study is to determine if HBOT improves clinical outcomes in children with autism. The study will also determine if HBOT changes markers of inflammation and oxidative stress in autistic children.

NCT ID: NCT00311259 Not yet recruiting - Oxidative Stress Clinical Trials

Melatonin Treatment and Inflammation, Oxidative Stress and Autonomic Function in Connection With Surgery

Start date: May 2006
Phase: Phase 2
Study type: Observational

The purpose of this study is to determine whether treatment with melatonin can reduce cell damage and inflammation in connection with laparoscopic gall bladder surgery.

NCT ID: NCT00271141 Recruiting - Parkinson's Disease Clinical Trials

Multifunctional Substrate for Early Detection of Oxidative Stress Susceptibility and Application to Parkinson's Disease

Start date: May 2005
Phase: N/A
Study type: Observational

The proposed work is based on the detection of a novel molecule for sensitivity to oxidative stress in humans in venous blood

NCT ID: NCT00263367 Completed - Autism Clinical Trials

Effect of Hyperbaric Therapy on Markers of Oxidative Stress in Children With Autism

Start date: October 2005
Phase: N/A
Study type: Interventional

This study will look at the changes taking place in the blood levels of key markers of oxidative stress. Oxidative stress is the biological equivalent of rust on a car. It changes vital cell chemistry. It is known to occur at high pressure oxygen, but little is known about changes at pressures slightly greater than normal atmospheric pressure. Hyperbaric therapy is used in a variety of medical conditions. It is being tested in this study only for safety. It is not being assessed for the ability of hyperbaric oxygen to improve the clinical condition of children with autism. This study was felt to be important since autism appears to be associated with oxidative stress and hyperbarics was being used "off-label" for this condition without safety studies.

NCT ID: NCT00253773 Completed - Oxidative Stress Clinical Trials

Metabolic Effects of Chemical Interactions in Toxicity

Start date: January 2005
Phase: N/A
Study type: Interventional

This pilot study tests the feasibility of using GSH redox state and high resolution proton NMR spectroscopy (1H-NMR) to detect metabolic changes due to acetominophen and sulfur amino acid deficiency. Our central hypothesis is that the a 2-day sulfur amino acid deficiency will alter acetominophen metabolism, acetominophen will affect sulfur amino acid homeostasis, and the treatments together will alter the global metabolic profile, as measured by 1H-NMR spectroscopy.

NCT ID: NCT00253760 Completed - Diabetes Clinical Trials

Metabolic Analysis in Human Sulfur Amino Acid Deficiency

Start date: February 2004
Phase: N/A
Study type: Interventional

Varied food intake, disease, and genetic differences result in complex diet-health interactions. In principle, information-rich metabolic analyses combined with bioinformatic tools provide an approach to explore these interactions. This project is a feasibility study of the use of high-resolution 1H-nuclear magnetic resonance (NMR) to study metabolic perturbations induced by a deficiency in sulfur amino acids (SAA). The investigators will 1) test the hypothesis that deficient dietary intake of SAA in humans results in oxidation of reduced glutathione (GSH)/oxidized glutathione (GSSG) redox and 2) determine whether 1H-NMR of blood and urine detects metabolic changes due to SAA deficiency.

NCT ID: NCT00247507 Active, not recruiting - Anemia Clinical Trials

The Effects of Acetylcysteine on Alleviating Damage of Oxidative Stress in Hemodialysis Patients

Start date: September 2005
Phase: Phase 4
Study type: Interventional

The aim of this study is to explore and identify the effects of acetylcysteine, a common mucolytic with anti-oxidant property, on alleviating the damage caused by increased oxidative stress in hemodialysis patients.

NCT ID: NCT00100269 Completed - Oxidative Stress Clinical Trials

Menevit Study: Menevit Anti-Oxidant Therapy for the Treatment of Male Infertility

Start date: December 2004
Phase: Phase 3
Study type: Interventional

Oxidative stress related damage to sperm is believed to be a major cause of male infertility. The object of the Menevit study is to investigate the role of a novel anti-oxidant preparation (Menevit) on sperm function, embryo quality and pregnancy rates in an in vitro fertilization (IVF) setting.